Literature DB >> 11979085

Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma.

John D Henley1, Robert H Young, Thomas M Ulbright.   

Abstract

The distinction of Sertoli cell tumors from seminoma is critical to ensure proper treatment. Although usually straightforward, we highlight herein 13 malignant Sertoli cell tumors of the testis with light microscopic features that mimicked seminoma. All of the cases were received in consultation, 10 with submitting diagnoses of seminoma, usually of classic type, but three cases of spermatocytic type. Patients ranged from 15 to 80 years of age (median 37 years); all presented with testicular masses. The tumors were typically firm, white to yellow-tan, and often had foci of hemorrhage. The dominant microscopic pattern was nested or sheet-like, with some tumors having secondary patterns of trabeculae-solid tubules, hollow tubules, and pseudofollicles. Tumor cells were polygonal with conspicuous clear cytoplasm in 12 cases; the cytoplasm was focally eosinophilic in 10 cases, but this was never conspicuous. Nine tumors had cytoplasmic vacuoles, and three of four that were investigated stained for intracytoplasmic glycogen. Nuclei were small (5) to medium-sized (8), round-to-oval (13), and vesicular with irregular contours (11). Nucleoli were present in 11 tumors (six small; five large). Stromal fibrosis (12) and lymphoid infiltrates (10) were conspicuous, and tumor necrosis (11) and vascular invasion (8) also were seen. Mitotic figures ranged from <1 to 21/10 high power fields (HPF) (median 1/10 HPF). Staining for inhibin-alpha, epithelial membrane antigen, and cytokeratin (AE1/AE3) was positive in four of four, six of six, and three of six cases, respectively; placental alkaline phosphatase was negative in all five tumors investigated. The nested growth pattern, prominence of clear cells, lymphoid infiltrate, inconspicuous tubular differentiation, cytoplasmic glycogen, and prominent nucleoli caused these tumors to be mistaken for seminomas. The smaller, less pleomorphic nuclei of Sertoli cell tumors, their lower mitotic rate, and the absence of intratubular germ cell neoplasia are helpful differential features. Immunohistochemistry is a useful adjunct in confirming the diagnosis of Sertoli cell tumor, but only if the overlapping features are appreciated by conventional microscopy and the diagnosis of Sertoli cell tumor included in the differential.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979085     DOI: 10.1097/00000478-200205000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  [Malignant Sertoli cell tumors of the testes].

Authors:  K Günzel; H Wegner; H Cash; P Lohneis; C Kempkensteffen; K Miller; S Hinz
Journal:  Urologe A       Date:  2015-08       Impact factor: 0.639

Review 2.  Morphological approach to tumours of the testis and paratestis.

Authors:  Robert E Emerson; Thomas M Ulbright
Journal:  J Clin Pathol       Date:  2007-02-16       Impact factor: 3.411

3.  Molecular-cytogenetic characterisation of sex cord-stromal tumours: CGH analysis in sertoli cell tumours of the testis.

Authors:  I Verdorfer; A Höllrigl; U Strasser; M Susani; A Hartmann; H Rogatsch; G Mikuz
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

Review 4.  [Endocrine tumors of the testis].

Authors:  V Loy; J Linke
Journal:  Pathologe       Date:  2003-05-13       Impact factor: 1.011

5.  Non-Leydig sex-cord tumors of the testis. The place of immunohistochemistry in diagnosis and prognosis. A study of twenty cases.

Authors:  Eva Compérat; Fréderique Tissier; Karine Boyé; Gonzague De Pinieux; Annick Vieillefond
Journal:  Virchows Arch       Date:  2004-04-16       Impact factor: 4.064

Review 6.  [Testicular seminomas. The classical and the less classical ones].

Authors:  P K Bode; H Moch
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

7.  Overactive beta-catenin signaling causes testicular sertoli cell tumor development in the mouse.

Authors:  Hao Chang; Florian Guillou; Makoto M Taketo; Richard R Behringer
Journal:  Biol Reprod       Date:  2009-06-24       Impact factor: 4.285

8.  Synchronous Leydig Cell Tumor and Seminoma in the Ipsilateral Testis.

Authors:  Ifeyinwa E Obiorah; Alexandra Kyrillos; Metin Ozdemirli
Journal:  Case Rep Urol       Date:  2018-02-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.